Sept 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- RECCE PHARMACEUTICALS ANNOUNCES POSITIVE & CONCENTRATION-DEPENDENT EFFICACY OF RECCE® COMPOUNDS AGAINST COVID-19 IN INTERNATIONAL STUDY
- RECCE PHARMACEUTICALS - R327, R529 COMPOUNDS SHOW CONCENTRATION-DEPENDENT FALL IN COVID-19 IN-VITRO STUDY USING ORGANOIDS MADE FROM HUMAN AIRWAY EPITHELIAL CELLS
- RECCE PHARMACEUTICALS - CONCENTRATIONS OF R327, R529 TESTED, FURTHER INDICATED EXCELLENT TOXICITY PROFILE ON VERO CELLS, IN SEPARATE BUT RELATED STUDY
News: RCE Recce Pharmaceuticals Announces Positive & Concentration-Dependent Efficacy Of Recce®...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.010(2.44%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 43.0¢ | 40.0¢ | $45.78K | 109.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23268 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 65639 | 6 |
View Market Depth
| Last trade - 12.43pm 12/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |